A study presented at #EAU24 sought to determine the utility of ctDNA in connection with pathologic and clinical features in testicular cancer.

Previous trials have revealed that neoadjuvant chemotherapy is an effective treatment path for patients with high-grade UTUC. A recent analysis sought to determine the potential benefits of perioperative chemotherapy for patients with high-grade UTUC who undergo nephroureterectomy.

Most retrospective reports are limited due to selection bias, where patients in poor health are more frequently treated with radiotherapy.
New research compared PCSM in cN1 patients with PCa who received RP versus RT in an other-cause mortality-weighted cohort.

Rsearchers designed an analysis to better understand the factors that lead to renal function improvement after partial nephrectomy. Partial nephrectomy is considered a viable management strategy for patients with localized renal masses.

Some patients who meet the FDA criteria for “BCG-unresponsive” bladder cancer may benefit from additional BCG therapy, according to a new study presented at the 2024 European Association of Urology Congress.